InvestorsHub Logo
Followers 30
Posts 5046
Boards Moderated 0
Alias Born 01/07/2020

Re: lizzy241 post# 417864

Thursday, 11/09/2023 2:04:14 PM

Thursday, November 09, 2023 2:04:14 PM

Post# of 425662
lizzy, Actual rise in revenue for a change 🙂

Q3 & YEAR-TO-DATE ("YTD") 2023 FINANCIAL & OPERATIONAL HIGHLIGHTS

Q3 2023 Vascepa net revenue was C$4.7 million, up 44% compared to C$3.2 million in Q3 2022.
Vascepa total prescriptions in Q3 2023 increased by 89% year-over-year from Q3 2022.
Vascepa prescribers in Q3 2023 increased 86% year-over-year from Q3 2022.
Vascepa consistent prescribers2 in Q3 2023 increased by 97% year-over-year from Q3 2022.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News